The emergence of lncRNAs in cancer biology
Explore this paper's citation graph
Summary
This review will highlight the emerging impact of ncRNAs in cancer research, with a particular focus on the mechanisms and functions of lncRNAs.
- Type
- review
- Published
- 2011-10-01
- Cited by
- 1,753
- References
- 108
- Access
- Open access
- OpenAlex
- https://openalex.org/W2110957978
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:3009799
Keywords
Biology, Computational biology, Cancer, Identification (biology), Non-coding RNA
References
- The H19 Non-Coding RNA Is Essential for Human Tumor Growth
- Gene Index analysis of the human genome estimates approximately 120,000 genes
- Inactivation of imprinted genes induced by cellular stress and tumorigenesis.
- A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
- Misbehaviour of XIST RNA in Breast Cancer Cells
- A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome
- The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.
- Expression of Linear and Novel Circular Forms of an INK4/ARF-Associated Non-Coding RNA Correlates with Atherosclerosis Risk
- Polycomb proteins targeted by a short repeat RNA to the mouse X-chromosome
- Identification of new genes by systematic analysis of cDNAs and database construction.
- 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC
- XIST unmethylated DNA fragments in male-derived plasma as a tumour marker for testicular cancer.
- Structural and Functional Differences in the Long Non-Coding RNA Hotair in Mouse and Human
- Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells.
- X inactivation and the complexities of silencing a sex chromosome.
- BRCA1 supports XIST RNA concentration on the inactive X chromosome.
- CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes.
- Reprogramming Transcription via Distinct Classes of Enhancers Functionally Defined by eRNA
- Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals
- Ab initio reconstruction of transcriptomes of pluripotent and lineage committed cells reveals gene structures of thousands of lincRNAs
Cited by
- [Models of oncogenesis: an endless world?].
- Methods for the Study of Long Noncoding RNA in Cancer Cell Signaling
- Non-coding RNAs in DNA damage response.
- Long Noncoding RNAs-Related Diseases, Cancers, and Drugs
- Linking the SWI/SNF complex to prostate cancer
- Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
- Altered Long Noncoding RNA Expression Precedes the Course of Parkinson’s Disease—a Preliminary Report
- Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.
- RNA metabolism in neurodegenerative disease
- TFPI2AS1, a novel lncRNA that inhibits cell proliferation and migration in lung cancer
- LncRNA EGOT Promotes Tumorigenesis Via Hedgehog Pathway in Gastric Cancer
- A comprehensive genome-wide analysis of the long noncoding RNA expression profile in metastatic lymph nodes of oral mucosal melanoma.
- Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
- Epigenetic basis for Tensin3 dysregulation in human renal cell carcinoma
- Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
- Long non-coding RNAs (lncRNAs) and viral infections
- Regulators of gene expression as biomarkers for prostate cancer.
- The RNA HOTAIR Promotes Chromatin Alteration in Cancer.
- Discovery and Characterization of Long Non-coding RNAs in Prostate Cancer.
- Unexpected roles of long non-coding RNAs in cancer biology
Related papers
- Identification of a 5-gene signature panel for the prediction of prostate cancer progression
- Androgen Receptor Antagonists for the Treatment of Prostate Cancer
- RNase P RNA ofMycoplasma capricolum
- The extracellular RNA complement of Escherichia coli
- 5′ and 3′ modifications controlling RNA degradation: from safeguards to executioners
- Visualization and characterization of RNA–protein interactions in living cells
- Decoding microRNA drivers in atherosclerosis
- Noncoding RNAs in Cardiovascular Disease: Pathological Relevance and Emerging Role as Biomarkers and Therapeutics.